Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hambleton

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The Journal of Hygiene|June 1, 1983
Survival of virulent Legionella pneumophila in aerosolsP Hambleton, M G Broster, P J Dennis, et al.
European Journal of Biochemistry|January 15, 1986
Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranesD M Evans, R S Williams, C C Shone, et al.
The Journal of Applied Bacteriology|September 1, 1987
Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat systemA M Gibson, N K Modi, T A Roberts, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1982
Localization of sites for 125I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomesJ O Dolly, R S Williams, J D Black, et al.
The Journal of Applied Bacteriology|September 1, 1988
Studies on the irradiation of toxins of Clostridium botulinum and Staphylococcus aureusS A Rose, N K Modi, H S Tranter, et al.
The Biochemical Journal|May 15, 1990
Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomesJ D Wadsworth, M Desai, H S Tranter, et al.
Transplantation Proceedings|December 1, 1996
Dihydroorotate dehydrogenase is a target for the biological effects of leflunomideR A Williamson, C M Yea, P A Robson, et al.
The Journal of Biological Chemistry|September 22, 1995
Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compoundR A Williamson, C M Yea, P A Robson, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The Journal of Hygiene|June 1, 1983
Survival of virulent Legionella pneumophila in aerosolsP Hambleton, M G Broster, P J Dennis, et al.
European Journal of Biochemistry|January 15, 1986
Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranesD M Evans, R S Williams, C C Shone, et al.
The Journal of Applied Bacteriology|September 1, 1987
Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat systemA M Gibson, N K Modi, T A Roberts, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1982
Localization of sites for 125I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomesJ O Dolly, R S Williams, J D Black, et al.
The Journal of Applied Bacteriology|September 1, 1988
Studies on the irradiation of toxins of Clostridium botulinum and Staphylococcus aureusS A Rose, N K Modi, H S Tranter, et al.
The Biochemical Journal|May 15, 1990
Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomesJ D Wadsworth, M Desai, H S Tranter, et al.
Transplantation Proceedings|December 1, 1996
Dihydroorotate dehydrogenase is a target for the biological effects of leflunomideR A Williamson, C M Yea, P A Robson, et al.
The Journal of Biological Chemistry|September 22, 1995
Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compoundR A Williamson, C M Yea, P A Robson, et al.
Pageof 7